243 related articles for article (PubMed ID: 16305638)
21. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome?
Pers JO; d'Arbonneau F; Devauchelle-Pensec V; Saraux A; Pennec YL; Youinou P
Arthritis Rheum; 2005 Aug; 52(8):2411-4. PubMed ID: 16052575
[TBL] [Abstract][Full Text] [Related]
22. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.
Pers JO; Devauchelle V; Daridon C; Bendaoud B; Le Berre R; Bordron A; Hutin P; Renaudineau Y; Dueymes M; Loisel S; Berthou C; Saraux A; Youinou P
Arthritis Rheum; 2007 May; 56(5):1464-77. PubMed ID: 17469105
[TBL] [Abstract][Full Text] [Related]
23. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
[TBL] [Abstract][Full Text] [Related]
24. Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome.
Stott DI; Hiepe F; Hummel M; Steinhauser G; Berek C
J Clin Invest; 1998 Sep; 102(5):938-46. PubMed ID: 9727062
[TBL] [Abstract][Full Text] [Related]
25. An APRIL to remember: novel TNF ligands as therapeutic targets.
Dillon SR; Gross JA; Ansell SM; Novak AJ
Nat Rev Drug Discov; 2006 Mar; 5(3):235-46. PubMed ID: 16474316
[TBL] [Abstract][Full Text] [Related]
26. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells.
Le Pottier L; Devauchelle V; Fautrel A; Daridon C; Saraux A; Youinou P; Pers JO
J Immunol; 2009 Mar; 182(6):3540-7. PubMed ID: 19265132
[TBL] [Abstract][Full Text] [Related]
27. Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome.
Hansen A; Gosemann M; Pruss A; Reiter K; Ruzickova S; Lipsky PE; Dörner T
Arthritis Rheum; 2004 Jun; 50(6):1897-908. PubMed ID: 15188366
[TBL] [Abstract][Full Text] [Related]
28. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
[TBL] [Abstract][Full Text] [Related]
29. The role of BAFF in immune function and implications for autoimmunity.
Kalled SL
Immunol Rev; 2005 Apr; 204():43-54. PubMed ID: 15790349
[TBL] [Abstract][Full Text] [Related]
30. BAFF overexpression increases lymphocytic infiltration in Sjögren's target tissue, but only inefficiently promotes ectopic B-cell differentiation.
Ding J; Zhang W; Haskett S; Pellerin A; Xu S; Petersen B; Jandreski L; Hamann S; Reynolds TL; Zheng TS; Mingueneau M
Clin Immunol; 2016 Aug; 169():69-79. PubMed ID: 27352977
[TBL] [Abstract][Full Text] [Related]
31. Neuroendocrine dysfunction in Sjogren's syndrome.
Tzioufas AG; Tsonis J; Moutsopoulos HM
Neuroimmunomodulation; 2008; 15(1):37-45. PubMed ID: 18667798
[TBL] [Abstract][Full Text] [Related]
32. The mosaic of B-cell subsets (with special emphasis on primary Sjögren's syndrome).
Le Pottier L; Devauchelle V; Pers JO; Jamin C; Youinou P
Autoimmun Rev; 2007 Jan; 6(3):149-54. PubMed ID: 17289550
[TBL] [Abstract][Full Text] [Related]
33. BAFF: a fundamental survival factor for B cells.
Mackay F; Browning JL
Nat Rev Immunol; 2002 Jul; 2(7):465-75. PubMed ID: 12094221
[TBL] [Abstract][Full Text] [Related]
34. Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas.
Sutherland AP; Mackay F; Mackay CR
Pharmacol Ther; 2006 Dec; 112(3):774-86. PubMed ID: 16863659
[TBL] [Abstract][Full Text] [Related]
35. Progress and regression within primary Sjögren's syndrome.
Manthorpe R; Bredberg A; Henriksson G; Larsson A
Scand J Rheumatol; 2006; 35(1):1-6. PubMed ID: 16467033
[TBL] [Abstract][Full Text] [Related]
36. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.
Haiat S; Billard C; Quiney C; Ajchenbaum-Cymbalista F; Kolb JP
Immunology; 2006 Jul; 118(3):281-92. PubMed ID: 16827889
[TBL] [Abstract][Full Text] [Related]
37. BAFF, APRIL and human B cell disorders.
Tangye SG; Bryant VL; Cuss AK; Good KL
Semin Immunol; 2006 Oct; 18(5):305-17. PubMed ID: 16916610
[TBL] [Abstract][Full Text] [Related]
38. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
39. BAFF, APRIL, TWE-PRIL: who's who?
Daridon C; Youinou P; Pers JO
Autoimmun Rev; 2008 Feb; 7(4):267-71. PubMed ID: 18295728
[TBL] [Abstract][Full Text] [Related]
40. BAFF: a novel therapeutic target for autoimmunity.
Kalled SL
Curr Opin Investig Drugs; 2002 Jul; 3(7):1005-10. PubMed ID: 12186259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
